In virtue of its anti-inflammatory effect of metformin improves cognitive function and may attenuate the progression of AD neuropathology via induction of Aβ clearance with inhibition of tau protein phosphorylation and associated neuroinflammation [138]. This evidence concerns the gene MAPT and Alzheimer disease.